Webinars and Commercial Conversations — Register Now

Tuesday, December 1, 2026, 1 PM-2 PM ET

Join UCSF clinical microbiologists as they share their journey from using multiple respiratory testing platforms to implementing a flexible, stewardship-driven testing strategy. Learn how customizable respiratory panels helped streamline workflows, improve efficiency, and better align testing with patient needs.

Webinar presenters Danielle Ingebrigtsen, MHS, Clinical Laboratory Scientist Supervisor, UCSF Health, and Rama Yakubu, MD, PhD, Assistant Professor of Laboratory Medicine, Co-Director of Microbiology, UCSF Health.

CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Diasorin.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Wednesday, December 9, 2026, 12 PM-1 PM ET
Hear an expert pathologist discuss the role of HER2 IHC testing and scoring in solid tumors including endometrial, ovarian, cervical, bladder, non-small cell lung, colorectal, and biliary cancers

Webinar presenter Michelle Shiller, DO, MSPT, Baylor Sammons Cancer Center; Fulgent Genetics; Texas Cancer Interception Institute

CAP TODAY does not endorse any of the products or services named within. This program is intended for US healthcare professionals. This program is being sponsored by AstraZeneca. The speaker is being compensated for the presentation. The program is not CME accredited and may not be used for CME accreditation.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Tuesday, January 12, 2027, 2 PM-3 PM ET
Hear Dr. Roden discuss how computational pathology will impact the practice & future of precision oncology, using global real world analytical evidence for the novel TROP2 NMR biomarker as an example.

Webinar presenter Anja C. Roden, MD, Consultant, Division of Anatomic Pathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Professor of Laboratory Medicine and Pathology
Mayo Clinic College of Medicine and Science, Rochester, Minnesota

CAP TODAY does not endorse any of the products or services named within. This program is being sponsored by Roche Diagnostics. The speaker is being compensated for the presentation. The program is not CME accredited and may not be used for CME accreditation.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Subspecialties

Interactive Product Guides

Manage Subscription

To receive CAP TODAY magazine, please subscribe here.
For change of address, mail new information to: CAP TODAY Circulation, 325 Waukegan Road, Northfield, IL 60093-2750 or visit here.

Columns

From the President’s Desk

November 2026—I had the pleasure last month of hosting the first-ever Global Community Reception at our CAP26 annual meeting in Las Vegas. It was a gathering of pathology leaders from outside the United States as well as senior leadership members from the CAP.

Clinical pathology selected abstracts

November 2026—Alpha-gal syndrome (AGS) is a newly described emerging noninfectious tickborne disease characterized by an allergic reaction to galactose-a-1,3-galactose (alpha-gal), an oligosaccharide found in red (mammalian) meat and other animal products, such as gelatin and dairy. As of 2022, an estimated 450,000 people in the United States had developed AGS.

Anatomic pathology selected abstracts

November 2026—Esophageal perforation (EP) is a rare but life-threatening condition, and most cases are due to iatrogenic causes. The remainder occur spontaneously and are due to malignancies or trauma.

Molecular pathology selected abstracts

November 2026—B-cell acute lymphoblastic leukemia (B-ALL) arises from a variety of genetic alterations impacting B-cell progenitors. Classification of B-ALL based on genetic type is associated with characteristic morphological, immunophenotypic, or clinical features with prognostic or therapeutic implications, or both.

Q&A column

November 2026
Q. How has the National Comprehensive Cancer Network guideline approach to cytogenetic testing in multiple myeloma evolved, and why does this matter for patient care? Read answer.
Q. If you find smudge cells in a blood smear when performing a manual differential count and their morphological features allow you to classify those cells, do you categorize them as smudge cells or based on their distinct features? At what percentage of smudge cells is an albumin preparation performed? Read answer.

Newsbytes

November 2026—Ask a random group of pathologists if they are familiar with lab automation, regardless of whether they use it, and you’re more than likely to get nods of affirmation all around. But follow that up by asking them if they are aware of the pros and cons and ins and outs of robotic process automation versus agentic artificial intelligence and many of those nodding heads may go still.

Put It on the Board

November 2026—Denials of clinical laboratory, molecular diagnostic, and genomics claims rose to 11.2 percent in 2025 from eight percent in 2024, a 40 percent jump that XiFin says erased two years of improvement, according to the company’s recently released 2026 Payor Denial Impact Report.

From the President’s Desk

October 2026—We have all heard the latest claims that the American Medical Association—and the medical specialties it represents—is misusing CPT codes to overpay physicians. Whether these statements come from the Medicare Payment Advisory Commission, members of Congress, or any other group, it’s no wonder we pathologists feel under attack.

Clinical pathology selected abstracts

October 2026—Evidence-based guidelines for platelet use help prevent unnecessary transfusion and inform better transfusion practice. Platelet transfusions can be used to prophylactically prevent bleeding or treat bleeding.

Anatomic pathology selected abstracts

October 2026—Primary endometrial carcinomas with somatically-derived yolk sac tumor components are rare. Therefore, the authors performed detailed clinicopathologic, immunohistochemical, and molecular analyses to better understand and address these entities.